INS and Hepatic steatosis: Notably, butanoate/butyrate production can be enhanced after bariatric surgery 69, while favorable effects of butyrate have been proved on MASLD, including attenuating hepatic steatosis and inflammation while enhancing insulin sensitivity 70.